Shanghai Biopharmaleader co.,ltd

Date: 18th July 2016
Enasidenib CAS:1446502-11-9
CAS NO.1446502-11-9Product Name EnasidenibSynonymsAG-221FormulaC19H17F6N7OMolecular Weight473.14Spec / Purity98%minSupply Capacity Details Enasidenib, aslo known as AG-221 and CC-90007, is a potent and selective IDH2 inhibitor with potential anticancer activity (IDH2 = Isocitrate dehydrogenase 2). The mutations of IDH2 present in certain cancer cells result in a new ability of the enzyme to catalyze the NAPH-dependent reduction of ?-ketoglutarate to R(-)-2-hydroxyglutarate (2HG). The production of 2HG is believed to contribute to the formation and progression of cancer . The inhibition of mutant IDH2 and its neoactivity is therefore a potential therapeutic treatment for cancer.?
Images
Latest News
Contact Information
Phone:
86-021-50180596
Fax:

86-021-57758967

Address:

Building 11, NO. 3802 ShenGang Rd, Xinfei Corporation Home, SongJiang District, Shanghai,201611, China.
Shanghai, 201611

Website:

www.biopharmaleader.net

Contact Form